George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Regulatory News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

21 Aug 2018 15:28

RNS Number : 4726Y
Sensyne Health PLC
21 August 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Sensyne Health Ltd

Sedol BYV3J75

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Placing of shares

X

3. Details of person subject to the notification obligationiv

Name

1Lansdowne Partners International Limited

2Lansdowne Partners Limited

3Lansdowne Partners (UK) LLP

4Lansdowne Developed Markets Master Fund Limited

 

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

Aurora Nominees Ltd

Morgan Stanley Client Securities Nominees Ltd

(Registered Shareholders)

City and country of registered office (if applicable)

n/a

5. Date on which the threshold was crossed or reachedvi:

17/08/2018

6. Date on which issuer notified (DD/MM/YYYY):

20/08/2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

10.41%

10.41%

128,571,514

Position of previous notification (if

applicable)

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BYV3J755

13,384,497

10.41%

SUBTOTAL 8. A

13,384,497

10.41%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Lansdowne Partners

International Limited

10.41%

10.41%

Lansdowne Partners

Limited

Lansdowne Partners (UK) LLP

10.41%

10.41%

Lansdowne Developed Markets Master Fund Limited

9.03%

9.03%

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

London

Date of completion

20 August 2018

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLZMGZRDMVGRZM
Date   Source Headline
19th Aug 20202:00 pmRNSPrice Monitoring Extension
19th Aug 20207:00 amRNSDevelopment of ‘DBm-Health™’ for diabetes
17th Aug 20204:41 pmRNSSecond Price Monitoring Extn
17th Aug 20204:36 pmRNSPrice Monitoring Extension
13th Aug 20202:06 pmRNSSecond Price Monitoring Extn
13th Aug 20202:00 pmRNSPrice Monitoring Extension
10th Aug 20207:00 amRNSSensyne Health settles employment tribunal claim
20th May 202011:05 amRNSSecond Price Monitoring Extn
20th May 202011:00 amRNSPrice Monitoring Extension
19th May 20204:00 pmRNSLaunch of CVm-Health app in the US
14th May 20207:00 amRNSTrading and Business Update
5th May 20207:00 amRNSSensyne Health launches BPm-Health product
20th Apr 20207:00 amRNSLaunch of CVm-Health ‘Good Neighbour’ app
9th Apr 20204:41 pmRNSSecond Price Monitoring Extn
9th Apr 20204:37 pmRNSPrice Monitoring Extension
30th Mar 20202:05 pmRNSSecond Price Monitoring Extn
30th Mar 20202:00 pmRNSPrice Monitoring Extension
27th Mar 20204:42 pmRNSSecond Price Monitoring Extn
27th Mar 20204:37 pmRNSPrice Monitoring Extension
27th Mar 20202:52 pmRNSGDm-Health free to NHS in response to COVID-19
11th Mar 20209:00 amRNSHolding(s) in Company
2nd Mar 20205:29 pmRNSInterim Chief Financial Officer appointment
2nd Mar 20208:18 amRNSDirectorate Change
28th Feb 20204:00 pmRNSHSJ Partnership Award for GDm-Health
3rd Feb 20207:00 amRNSHoldings in Company
21st Jan 20207:00 amRNSSensyne Health confirms benefits in study
21st Jan 20207:00 amRNSSensyne Health Interim Results
16th Jan 20202:05 pmRNSSecond Price Monitoring Extn
16th Jan 20202:00 pmRNSPrice Monitoring Extension
23rd Dec 20197:00 amRNSSensyne Health enters AI research collaboration
20th Dec 20199:00 amRNSNotice of Results
16th Dec 20197:00 amRNSUpdate Following General Election
10th Dec 20197:00 amRNSBoard Changes
15th Nov 20197:00 amRNSCognizant and Agorai named as partners
30th Oct 20192:28 pmRNSResult of AGM
30th Oct 20197:41 amRNSDirectorate Change
22nd Oct 20197:00 amRNSAppointment of Joint Broker and Financial Adviser
22nd Oct 20197:00 amRNSRemuneration Policy and Corporate Governance
17th Oct 20195:21 pmRNSHolding(s) in Company
15th Oct 20195:16 pmRNSHolding(s) in Company
10th Oct 20197:00 amRNSSensyne extends partnership with Bayer
7th Oct 20197:00 amRNSAnnual Report and Accounts
7th Oct 20197:00 amRNSCollaboration with UK MHRA
7th Oct 20197:00 amRNSMajor Agreements for digital health products in US
7th Oct 20197:00 amRNSSensyne Health Maiden Full Year Results
4th Oct 20197:00 amRNSBoard Change
4th Oct 20197:00 amRNSRelated party transactions
23rd Sep 201912:00 pmRNSBoard Change
12th Sep 20197:00 amRNSNotice of Full Year Results
2nd Aug 201912:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.